Other Contributions

2017

  • Christa Müller, Barbara Stegmann, Konrad Wehrhahn, Frank Weinsberg, Barbara Maertens: Neuroallianz. UniBonnTV, Video on YouTube.

  • Christa Müller: Neuroallianz: A New Academia-Industry Partnership Model for Promoting Innovation in Drug Discovery. Presentation by Christa Müller at Annual DPhG Meeting (Ger-man Pharmaceutical Society Annual Conference) in Saarbrücken in September 2017.

  • Barbara Wenzel: Development of fluorine-18 labelled radioligands for imaging the adenosine A2B receptor. Publication on HZDR web page (Department of Neuroradiopharmaceuticals, Research site Leipzig), May 2017.

  • Marcel Lindemann, Barbara Wenzel, Sonja Hinz, Sladjana Dukic-Stefanovic, Winnie Deuther-Conrad, Rodrigo Teodoro, Cathleen Juhl, Christa E. Müller, Peter Brust, Jörg Steinbach: Entwicklung des ersten F-18-markierten Radioliganden zur molekularen Bildgebung des Adenosinrezeptors A2B im Gehirn. Presentation at DGN 2017, Dresden, 28 April 2017.

  • Marcel Lindemann, Barbara Wenzel, Sonja Hinz, Sladjana Dukic-Stefanovic, Winnie Deuther-Conrad, Rodrigo Teodoro, Cathleen Juhl, Christa E. Müller, Peter Brust, Jörg Steinbach: Development of the first fluorine-18 labelled radioligand for imaging of the adenosine A2B receptor. 22nd International Symposium on Radiopharmaceutical Sciences, 2017.

  • Marcel Lindemann, Barbara Wenzel, Sonja Hinz, Sladjana Dukic-Stefanovic, Winnie Deuther-Conrad, Rodrigo Teodoro, Cathleen Juhl, Christa E. Mueller, Peter Brust, Joerg Steinbach: Entwicklung des ersten F-18-markierten Radioliganden zur molekularen Bildgebung des Adenosinrezeptors A2B im Gehirn. Abstract for Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin, Dresden, 26-29 April 2017.

  • Marcel Lindemann, Barbara Wenzel, Sonja Hinz, Sladjana Dukic-Stefanovic, Winnie Deuther-Conrad, Rodrigo Teodoro, Cathleen Juhl, Christa E. Mueller, Peter Brust, Joerg Steinbach: Development of the first fluorine-18 labelled radioligand for imaging of the adenosine A2B receptor. Abstract for 22nd Internat,onal Symposium on Radiopharmaceutical Sciences, Dresden, 14-19 May 2017.

2016

  • Press Release: Neuroallianz Publication Award 2016. 23 November 2016.

  • Sven Hodapp, Sumit Madan, Juliane Fluck, and Marc Zimmermann: Integration of UIMA Text Mining Components into an Event-based Asynchronous Microservice Architecture. Presentation of Martin Hofmann-Apitius at Workshop on Cross-Platform Text Mining and Natural Language Processing Interoperability at LREC 2016

  • Thanigaimalai Pillaiyar,Younis Baqi, Samer Alshaibani, Yuliya Tokar, Aliaa Abdelrahman, Vigneshwaran Namasivayam, Andreas Spinrath, Evi Kostenis, Christa E. Müller: Structure-activity relationships of 2-carboxy-1H-indole-3-propionic acid derivatives as potent agonists of the orphan G protein-coupled receptor GPR17. Conference abstract and poster for Frontiers in Medicinal Chemistry, 13-16 March 2016, Bonn, Germany.

  • University of Tuebingen, Pierre Koch: Pharmazeutisches Institut und Teva-ratiopharm entwickeln gemeinsam Wirkstoffe gegen die Alzheimerkrankheit. Press release University of Tübingen, February 2016.

2015

  • Anandhi Iyappan, Shweta Bagewadi, Philipp Senger, Matthew Page, Martin Hofmann-Apitius: NeuroRDF: Semantic Data Integration Strategies for Modeling Neurodegenerative Disease. Proceedings of 6th International Symposium on Semantic Mining in Biomedicine (SMBM), 2015.

  • Christa Mueller: Neuroallianz Consortium – Example of an Academic-Industrial Collaboration. Presentation at Annual DPhG Meeting in Düsseldorf on 23-25 SEP 2015.

  • H. Esselmann, C. Hafermann, O. Jahn, I. Kraus, J. Vogelgsang, U. Haußmann, Marina Uecker, Thomas Liepold, H. Klafki, J. Wiltfang: Analytical Methods to Explore Amyloid-β-Peptide Variants Beyond Aβ1-40 and Aβ1-42. Poster abstract and poster presentation for 29 AGNP symposium in Munich from 23 till 29 September 2015.

  • University of Tübingen: Neuroallianz fördert erstes Verbundprojekt am Pharmazeutischen Institut. Press release University of Tübingen, August 2015.

  • Shweta Bagewadi, Subash Adhikari, Anjani Dhrangadhariya, Afroza Irin, Christian Ebeling, Matthew Page, Martin Hofmann-Apitius, Philipp Senger: Neurodegene-rative transcriptomic meta-data curation: Key issues in re-usability for large-scale meta-analysis. Biocuration Conference April 2015, Beijing, China.

2014

  • Press Release: Neuroallianz Publication Award 2014. 11 December 2014

  • Aliaa Abdelrahman, Anke C. Schiedel, Meryem Köse, Sonja Hinz, Maggi Burton, Michel Gillard, Marc de Ryck, Christa E. Müller: Identification and characteri-zation of P2X4 receptor agonists and antagonists by radioligand binding and calcium assays. Poster presentation at Purines 2014, 21-23 July 2014, Bonn, Germany.
     
  • Meryem Köse, Kirsten Ritter, Katharina Sylvester, Michel Gillard, Evi Kostenis, Christa E. Müller: Development of [(3)H]2-Carboxy-4,6-dichloro-1H-indole-3-propionic Acid ([(3)H]PSB-12150): A Useful Tool for Studying GPR17. Poster presentation at Purines 2014, 21-23 July 2014, Bonn, Germany.
     
  • Thanigaimalai Pillaiyar, Younis Baqi, Aliaa Abdelrahman, Vigneshwaran Namasivayam, Christa E. Müller: Design, synthesis and structure-activity relationship studies of 4/6-substituted 2-carboxy-1H-indole-3-propionic acid derivatives as GPR17 agonists. Purines 2014, 21-23 July 2014, Bonn, Germany.
     
  • Anandhi Iyappan, Shweta Bagewadi, Matthew Page, Martin Hofmann-Apitius, Philipp Senger: NeuroRDF: Semantic Data Integration Strategies for Neurodegenerative Disease Modeling. Abstract for 6th International Symposium on Semantic Mining in Biomedicine, 6-7 October, 2014, Aveiro, Portugal.

  • Anandhi Iyappan, Shweta Bagewadi, Matthew Page, Martin Hofmann-Apitius, Philipp Senger: NeuroRDF: Semantic Data Integration Strategies for Neurodegenerative Disease Modeling. Abstract for ISWC 2014 Conference, 19-23 October 2014, Trentino, Italy.
     
  • Christin Janßen, Ute Haußmann, Philipp Linning, Isaak Beyer, Matthias Staufenbiel, Hans-Joachim Knölker, Hans Klafki, Jens Wiltfang: Separation and detection of amino-terminally truncated Aβ peptides by capillary isoelectric focusing immunoassay. Poster for European Protein Simple User Meeting, 12-13 May 2014, Paris, France.

  • Yvonne Holighaus, Kamran Honarnejad, Alexander Pfeifer, Martin Citron, Patrick Downey: Constitutive tau secretion is independent of cell death in cultured tau over-expressing cells. Abstract for Parkinson’s Disease: Genetics, Mechanisms and Therapeutics. Keystone Symposia, March 2014, Colorado, US

  • Yvonne Holighaus, Kamran Honarnejad, Alexander Pfeifer, Martin Citron, Patrick Downey: Constitutive Tau Secretion is Independent of Cell Death in Cultured Cells Overexpressing Tau. Poster for Alzheimer’s Disease: From Fundamental Insights to Light at the End of the Translational Tunnel. Keystone Symposia, March 2014, Colorado, US.

  • UCB: ZNS-Broschüre. Januar 2014.

2013

  • Press Release: Neuroallianz Publication Award 2013. November 2013

  • Cube Biotech Press Info: Cube Biotech receives funding from Neuroallianz Consortium. November 2013

  • UBonn Press Info: Erfolgversprechender Ansatz im Kampf gegen MS. October 2013

  • Anne Stößel, Sonja Hinz, Petra Küppers, Jag Heer, Michael Gütschow, Christa E. Müller: Dual Targeting of Adenosine A2A Receptors and Monoamine Oxidase B by 4H-3,1-Benzothiazin-4-Ones. Poster for Conference “Advanced Synthesis and Medicinal Chemistry” 5-8 May, Moscow.

  • PZB Homepage: ZukunftErfindenNRW – der Hochschulwettbewerb 2012. January/February 2013.

  • PZB Homepage: Neuroallianz-Konsortium mit insgesamt 40 Mio. € gefördert. January/February 2013.

  • Neuroallianz Web Page: Erster Neuroallianz Publication Award 2012. February 2013.

  • BioNRW Web Page: Erster Neuroallianz Publication Award 2012 (Newsletter und Instant Message). January 2013.

  • DAZ Press Release: Die Neuroallianz – eine Forschungskooperation im Rahmen der BioPharma-Initiative Deutschlands – vergibt die ersten Publikationspreise. January/February 2013.

  • PZB Homepage: Erster Neuroallianz Publication Award 2012 geht an Prof. Dr. Christa Müller und ihre Mitarbeiter. January/February 2013.

  • AK Müller Homepage: Erster Neuroallianz Publication Award 2012 geht an Prof. Dr. Christa Müller und ihre Mitarbeiter. January/February 2013.

  • PROvendis GmbH Pressemitteilung: Erfindungen aus NRW prägen die Zukunft. Preisverleihung des HochschulWettbewerbs ZukunftErfindenNRW 2012 – Erfindungen aus NRW zum Nutzen Aller. January 2013.

2012

  • First Neuroallianz Publication Award 2012/Erster Neuroallianz Publication Award - Auszeichnung der besten drei Veröffentlichungen. Press Release/Pressemitteilung 21. November 2012.

  • Fraunhofer-Institutszentrum Schloss Birlinghoven: Angewandte Forschung als Innovationsmotor für Unternehmen. Verlagsbeilage/Supplement Bonner General-Anzeiger. 20. November 2012.

  • Christa E. Müller, Alexander Pfeifer: 15 Millionen Euro für die „Neuroallianz“. Presse-Information der Universität Bonn. November 2012.

  • Reiner Dieden: Compound & Data Management in a highly networked environment. IQPC Compound Libraries, 15-17 October 2012.

  • Martin Hofmann-Apitius: New Ways to combat neurodegenerative diseases. Annual Report B-IT. September 2012

  • BioPharma-Wettbewerb: Zwei Konsortien erhalten weitere Förderung. Infobrief Forschung, Entwicklung, Innovation Nr. 31/2012, 30. August 2012, vfa - Die forschenden Unternehmen.

  • Neuroallianz Consortium receives additional EUR 15 million funding. Transkript, 2012.

  • IBL: IBL International and its partners in the Neuroallianz Consortium receive additional EUR 15 million funding. Press release, 23 August 2012.

  • UCB: UCB Deutschland, Industriepartner in erfolgreicher Forschungskooperation. Press release, 2012.

  • Fraunhofer SCAI: Neuroallianz erhält weitere 15 Millionen Euro Fördergelder. Presse releases in:
    • Biosprektrum, September 2012
    • Informationsdienst Wissenschaft, 22. August 2012
    • Uni Online, 22. August 2012
    • Uni Protokolle, 22. August 2012
    • JuraForum, 22. August 2012
    • Schattenblick-Meldung/591, 22. August 2012
    • Ärzte-Zeitung, Fachpresse und Online, 20. August 2012
    • Fraunhofer SCAI Internet, 17. August 2012
  • Fraunhofer SCAI: Mit Bioinformatik gegen Alzheimer. Press release in Kölner Stadtanzeiger, 2012.

  •  UCB: Konsortium präsentiert “Neuroallianz Publication Award”. Press release in Healthcare Marketing Journal, 21 May 2012.

  • Heidi Zinecker, Michael Hemmersbach, Christin Vielmuth, Gabriele M. König, Jörn Piel, Reiner Dieden, Christa E. Müller: The Compound Management Facility at the Pharma Center Bonn, University of Bonn. European Lab Automation 2012 (ELA 2012), Hamburg.

  • Fraunhofer SCAI: Neuroallianz: Innovative Therapeutics and Diagnostics for Neurodegenerative Disease. Fraunhofer SCAI Annual Report 2012.

  • Christa E. Müller, Jörg Hockemeyer, Nikolay Tzvetkov, Hamid Radjainia, Amelie Zech, Petra Küppers, Simone Siebers, Judith Paschkowiak and Meryem Köse: 8-Phenylethynylxanthines - highly potent and selective adenosine A2A receptor antagonists. International Conference EFMC/ISMC, Berlin 2012.

  • Victor Hernandez-Olmos, Aliaa Abdelrahman, Ali El-Tayeb, Diana Freudendahl, Stephanie Weinhausen, Marc De Ryck and Christa E. Müller: N-Substituted Phenoxazine and Acridone Derivatives: Structure-Activity Relationships of Potent P2X4 Receptor Antagonists. International Conference EFMC/ISMC, Berlin 2012.

  • Wadih Ghattas, Joachim C. Burbiel, Jörg Hockemeyer, and Christa E. Müller: [1,2,4]Triazolo[1,5-c]quinazolin-2-amines – potent adenosine A1 and A2A receptor antagonists. Purinergic Signalling, 2012, 8, 107-175.

  • Nikolay T. Tzvetkov, Petra Küppers, Jörg Hockemeyer and Christa E. Müller: N-Amino-substituted xanthine derivatives: affinity at adenosine receptors. Purinergic Signalling, 2012, 8, 107-175.

  • Amelie Zech, Jörg Hockemeyer, Nikolay Tzvetkov, Meryem Köse, Hamid Radjainia and Christa E. Müller: 8-Phenylethynylxanthines – highly potent and selective adenosine A2A receptor antagonists. Purinergic Signalling, 2012, 8, 107-175.

  • Petra Küppers, Amelie Zech, Simone Siebers, Judith Paschkowiak, Jörg Hockemeyer and Christa E. Müller: [3H]PSB-1010 - a new, optimized antagonist radioligand for adenosine A2A receptors. Purinergic Signalling, 2012, 8, 107-175.

  • Dominik Thimm, Miguel Moutinho, Anke C. Schiedel, Christa E. Müller: First Ade for Chinese hamsters - exploring a new adenine receptor. Purinergic Signalling, 2012, 8, 107-175.

  • Melanie Knospe, Anke C. Schiedel, Christa E. Müller: The predicted putative agonist binding site of the rat adenine receptor investigated by mutagenesis studies. Purinergic Signalling, 2012, 8, 107-175.


Neuroallianz-Partner interne Beiträge / Neuroallianz Partner Internal Contribution
s

  • UCB: Various internal communications across all parts of the global UCB organisation

2011

  • Christa E. Müller, Alexander Pfeifer: Die 72. Sendung von biotechnologie.tv, dem Nachrichtenmagazin auf biotechnologie.de, Beitrag 1: Neurodegenerative Erkrankungen effizient bekämpfen, 2011.

Die 72. Sendung von biotechnologie.tv, dem Nachrichtenmagazin auf biotechnologie.de.
Beitrag 1: Neurodegenerative Erkrankungen effizient bekämpfen

Facts

To provide the German location of biotechnology and pharma industry with fresh impulsion, the German Federal Ministry for Education and Research (BMBF) started the pharma initiative "BioPharma: The Strategy Competition for Future Medicines". The Neuroallianz Consortium was nominated for this initiative.

The Neuroallianz Consortium has created a novel strategic partnership where various academic institutions and companies are working jointly on innovative diagnostic and therapeutic research projects. The aim is to efficiently transform research into benefits for the patients.

Main focuses are diagnostic and therapy of neurodegenerative diseases such as Parkinson's Disease, or Alzheimer's Dementia, and Epilepsy.

Duration: 2009 – 2018

Budget: 40 Mio. €

Logo BMBF